Ras proteins are GTPases that regulate a wide variety of cellular functions, including growth and differentiation. Ras proteins must associate with cellular membranes to be biologically active (1-3). Synthesized on free polysomes as a hydrophilic protein, Ras associates secondarily with membranes as a consequence of a series of post-translational modifications of its carboxyl terminus (4 -8). Ras is a member of a large class of proteins that terminate in a CAAX motif (C, cysteine; A, usually aliphatic; X, any amino acid) that serves as a signal for modification. First the CAAX cysteine is farnesylated by addition of a 15-carbon polyisoprene lipid via a stable thioether linkage. The nascent farnesylated protein has affinity for the endoplasmic reticulum (ER) 1 (9) where it is acted upon by the Rce1 protease (10, 11) that removes the AAX amino acids from the farnesylated CAAX sequence. The newly exposed carboxylterminal farnesyl cysteine then becomes a substrate for prenylcysteine carboxyl methyltransferase (pcCMT) that methylesterifies the carboxyl group. Like Rce1, pcCMT is restricted to the ER (12). The net effect of these modifications is to remodel the hydrophilic carboxyl terminus of Ras into a hydrophobic domain that presumably interacts with the phospholipid bilayer. Ras isoform-specific differences have emerged for trafficking events following CAAX processing. For N-Ras and HRas, transport from the endomembrane to the plasma membrane (PM) proceeds via vesicular transport (9) and is absolutely dependent on palmitoylation of cysteines immediately upstream of the processed CAAX motif (9, 13, 14). K-Ras lacks palmitoylation sites and traffics to the PM by an as yet uncharacterized pathway that depends on a polylysine region adjacent to the CAAX sequence (14).
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The development of farnesyltransferase inhibitors has validated the Ras membrane trafficking pathway as a target for anti-cancer drug development (15) . Accordingly, much attention has been focused on the modifications that follow farnesylation. Although farnesylation of Ras clearly affords affinity for membranes (16) , the precise role of carboxyl methylation remains uncertain. Although methylesterification contributes to hydrophobicity by neutralizing the negative charge of the carboxyl terminal carboxyl group, the net additional hydrophobicity is small relative to that imparted by farnesylation, suggesting that this modification may play a role beyond nonspecific membrane affinity. Indeed, as the only modification of the CAAX sequence reversible at physiologic pH, carboxyl methylation has been postulated to modulate signaling events by regulating protein-protein interactions in much the same way as protein phosphorylation (17) .
Although mutation of the CAAX cysteine blocks all processing steps and renders Ras molecules inactive, carboxyl methylation cannot be specifically blocked by modification of the substrate because the only absolute requirement for pcCMT is the farnesylcysteine itself (18 -21) . The pcCMT gene has been targeted by homologous recombination and found to be essential for murine development, resulting in embryonic lethality at day 10.5 (22) . Spontaneously immortalized murine embryonic fibroblasts from pcCMTϪ/Ϫ embryos have been generated. Ras proteins are mislocalized to the cytosol (CS) of these cells (23) . Although these cells grow more slowly than those derived from wild-type littermates (22) , studies of the Ras signaling pathway have proven inconclusive because of the high background activity attributed to the spontaneous immortalization. An alternative approach to elucidating the role of carboxyl methylation in Ras signaling is to use pharmacologic inhibitors. In this study we have utilized N-acetyl-S-farnesyl-L-cysteine (AFC), a well established inhibitor of pcCMT (21, 24) , to block carboxyl methylation and determine the effects on Ras signaling. We have chosen to analyze the Ras/mitogen-activated protein kinase pathway downstream of the epidermal growth factor receptor (EGFR) because it is the most completely understood of the pathways regulated by Ras. Our results reveal that methylation mediates Ras signaling by two mechanisms. The first is to regulate membrane trafficking. The second is to mediate a trafficking-independent process likely to involve protein-protein interactions.
EXPERIMENTAL PROCEDURES
Materials-Unless otherwise stated, all materials were from Sigma. Myelin basic protein (MBP), penicillin/streptomycin (10,000 units/ml penicillin G and 10,000 g/ml streptomycin), and fetal bovine serum were from Invitrogen. Antisera and monoclonal antibodies were from Santa Cruz Biotechnology unless otherwise specified. [␥-
32 P]ATP was from Amersham Biosciences for most assays and from PerkinElmer Life Sciences for the Raf-1 kinase assay. Tris-glycine polyacrylamide gels were from Novex. Phosphocellulose circles (P81 filter paper) were from Whatman. Easy Tag™ [ 35 S]methionine/cysteine was from PerkinElmer Life Sciences. [ 3 H]methyl methionine was from Amersham Biosciences. Raf-1 immunoprecipitation kinase cascade assay kit (catalogue number 17-173) was from Upstate Biotechnology, Inc. Dulbecco's modified Eagle's medium and 2.5% trypsin were from BioWhittaker. SuperFect™ transfection kit was from Qiagen. AFC and N-acetyl-S-geranyl-L-cysteine (AGC) were from Biomol and were resuspended in dimethyl sulfoxide before use. Because AFC demonstrated as much as 40% variability in potency and toxicity between lots, all new lots of AFC were tested for toxicity and the maximum non-toxic concentration was normalized to a concentration of 150 M.
Cell Culture and Transfection-COS-1 cells and MDKC cells, obtained from the American Type Culture Collection, were cultured in 6-well plates according to the instructions of the supplier. For most experiments (see below), cells were grown to near confluency, followed by serum starvation for 24 -48 h prior to stimulation and/or other treatment. Cell toxicity of AFC was determined as lactate dehydrogenase release, measured by colorimetric LD-L 10 assay, according to the instructions of the manufacturer. For assays of cell proliferation, COS-1 cells were plated at dilutions sufficient to accomplish ϳ30% confluency. Cells were cultured overnight in Dulbecco's modified Eagle's medium/ 10% fetal bovine serum/penicillin/streptomycin, followed by replacement of the medium with identical medium containing AFC or AGC, and grown for 40 h. The cells were removed from the plate by trypsinization, diluted in Hank's balanced saline solution, and counted manually using a hemocytometer. Results of counting were expressed as cells/well ϫ 104.
For transfection experiments, COS-1 cells were seeded at a density of 1.32 ϫ 10 5 cells/well into 6-well plates and cultured overnight in Dulbecco's modified Eagle's medium/10% fetal bovine serum/penicillin/ streptomycin. Cells were washed once with Hank's balanced saline solution followed by transfection of plasmids using the SuperFect™ system according to the manufacturer's instructions. As an approximate measure of transfection efficiency in pcCMT transfection experiments, COS-1 cells were transfected with vector/green fluorescent protein (GFP)-pcCMT and transfection efficiency scored by the presence of green fluorescence. In these experiments, transfection efficiency ranged from 16 -21%. Stable MDCK cell lines containing GFP-H Ras, GFP-N Ras, and GFP-K Ras were as described previously (9) .
Erk and Mek Phosphorylation and Erk Kinase Activity-The phosphoactivation states of Erk and Mek were determined by subjecting experimental lysates to SDS-PAGE analysis, electrophoretic transfer to nitrocellulose and immunoblotting for the phosphorylated, active forms of Erk and Mek, respectively, as previously described (25) . Duplicate samples were similarly treated and immunoblotted for total levels of Erk and Mek, and Erk and Mek phosphorylation measurements were normalized to the total levels of these proteins.
To directly determine the kinase activity of Erk, COS-1 cells were prepared, treated, and lysed as described under "Results." Lysates were centrifuged (3000 ϫ g ϫ 10 min), the supernatants were immunoprecipitated for Erk 1 and 2, and the immunoprecipitants were assayed for their ability to phosphorylate MBP as previously described (26) . Duplicate assays in the absence of MBP were performed to determine background, non-MBP-directed kinase activities and subtracted from the measured MBP kinase activity.
Raf-1 Activity Assay-COS-1 cells were grown to near confluence in 75-cm 3 flasks, serum-starved for 24 -48 h, incubated with AFC (150 M) or AGC (150 M) for 16 h, and stimulated in the absence or presence of EGF (20 ng/ml) for 10 min, all at 37°C. Cells were lysed and centrifuged, and equivalent amounts (ϳ2 mg/experiment) of supernatant protein from each condition were assayed for Raf-1 kinase activity according to the directions of the assay kit manufacturer.
Ras Methylation Assay-COS-1 cells grown in 6-well plates were serum-starved for 4 h and then transferred to serum-free, methionine/ cysteine-free medium for 30 min at 37°C. The cells were incubated for an additional 30 min at 37°C in 25 Ci of Easy Tag™ [ (19, 24, 27) . The cells were lysed with radioimmune precipitation assay buffer (20 min at 4°C) and the lysates immunoprecipitated overnight using pan-Ras antibody Y13-259, followed by 1 h of incubation at room temperature with protein A-Sepharose. The pellets were recovered (centrifugation at 1000 ϫ g for 5 min) and analyzed by SDS-PAGE on 14% Tris-glycine gels followed by drying, autoradiography, and phosphorimaging. Visualized 35 S bands representing Ras on autoradiography were employed to localize Ras proteins on the original gels from which they were excised. Carboxyl terminal methylation of Ras in the excised gel fragments was then quantitated as previously described (20) and normalized to total Ras based on quantitation of 35 S Ras. EGFR Phosphorylation-COS-1 cells grown to near confluence in 75-cm 3 flasks were serum-starved for 24 h, incubated with AFC (150 M) or AGC (150 M) for 16 h, and stimulated for 10 min with EGF (20 ng/ml). Cells were lysed and centrifuged, and 1 mg of each supernatant was immunoprecipitated overnight with agarose bead-conjugated anti-EGFR antibodies (50 l of a 50% bead slurry) or protein A-conjugated agarose beads as controls. The samples were washed three times in phosphate-buffered saline, incubated with 25 l of sample buffer for 4 min at 100°C, and analyzed by 8 -16% gradient Tris-glycine SDS-PAGE, transfer to nitrocellulose, immunoblotting using antiphosphotyrosine antibodies and 125 I-protein A, and visualization and quantitation by phosphorimaging. Duplicate supernatants were analyzed by SDS-PAGE and immunoblotting for total EGFR, and the amount of phosphotyrosinolated EGFR was normalized to total quantities.
Plasmids-GFP-H Ras, GFP-N Ras, and GFP-K Ras were generated as described previously (9) . Myc-tagged and GFP-tagged pcCMT were also described previously (12) . For CD8-Ras constructs, the coding region of CD8 was amplified by polymerase chain reaction from cDNA using 5Ј-AGGCGGATCCGCCACCATGGCCTTACCAGTGACC forward and 5Ј-AGGCGAATTCCGACGTATCTCGCCGAAAG reverse primers and inserted in-frame into BamHI and EcoRI sites in the multiple cloning region of both pCDNA3.1/Hras and pCDNA3.1/Hras C184S described previously (9) . All constructs were verified by sequencing.
RESULTS

Inhibition of pcCMT Inhibits Erk Activation in COS-1
Cells-To determine the effects of inhibition of methylation on Erk activation, COS-1 cells were incubated for 18 h in the absence or presence of varying concentrations of AFC or the control compound AGC, followed by stimulation for 30 min with EGF (20 ng/ml), lysis, and determination of the phosphorylation state of Erk. EGF stimulation resulted in increased Erk phosphorylation (Fig. 1, A (top panel) and B) . Although both p44Erk1 and p42Erk2 were observed to undergo phosphorylation, p42Erk2 was the predominant isoform present in these cells. Preincubation with AFC resulted in dose-dependent inhibition of EGF-stimulated Erk activity. Maximum Erk inhibition was observed at concentrations of 150 M concordant with our previous reports that AFC inhibits methylation of Rasrelated proteins with maximal efficacy at that concentration (21, 24) . AFC had little or no effect on the total amount of Erk present (Fig. 1A, bottom panel) . AGC, a prenylcysteine analog that does not inhibit pcCMT activity (21, 24) , had no effect on Erk phosphorylation in response to EGF. Concentrations of AFC Յ 150 M had no effect on COS-1 cell viability as measured by lactate dehydrogenase release, although concentrations of Ͼ150 mM resulted in increasing amounts of lactate dehydrogenase release (Fig. 1C) . Accordingly, subsequent experiments were performed with AFC concentrations Յ 150 M. Although incubation of COS-1 cells for 12-24 h with 150 M AFC inhibited EGF stimulation of Erk, incubation for brief periods (Յ2 h) had no effect (Fig. 1D) . To confirm that the ability of AFC to inhibit Erk phosphorylation reflected inhibition of Erk kinase activity per se, we measured the ability of Erk to phosphorylate MBP in vitro. As shown in Fig. 1E , stimulation of COS-1 cells with EGF resulted in up-regulation of Erk kinase activity that was inhibited by preincubation of cells with AFC (150 M); thus, phosphoErk reporting was consistent with direct Erk activity assays. Consistent with its effects on a pathway implicated in the regulation of cell growth, preincubation of sparsely plated COS-1 cells with AFC resulted in retardation of cell proliferation (Fig. 1F) . 
AFC Inhibition of Erk Signaling Occurs at the Level of
Ras-To confirm that the effects of AFC on Erk activation were a consequence of its effects on Ras, we tested the ability of AFC to inhibit Erk signaling pathway elements proximal and distal to Ras. To confirm that AFC did not have a direct inhibitory effect on Erk activity, lysates of EGF-stimulated COS-1 cells were immunoprecipitated for total (phosphorylated and unphosphorylated) Erk 1 and 2 and the immunoprecipitates analyzed for their ability to phosphorylate MBP in the presence or absence of AFC. As shown in Fig. 1E , concentrations of AFC as high as 150 mM had no direct effect on Erk activity.
As shown in Fig. 2A , EGF stimulated Mek activation and AFC inhibited the activation of Mek by EGF. Concentrations of AFC required for Mek inhibition were similar to those required for inhibition of Erk, and AGC had no effect on Mek. AFC had little or no effect on total Mek levels in COS-1 cells. As in the case of Erk, the exposure time required for AFC to inhibit Mek activation was on the order of 12-18 h (Fig. 2B) . As shown in Fig. 2C, 16 h of exposure of COS-1 cells to 150 M AFC also inhibited Raf-1 activation. In contrast, AGC had no effect on Raf-1 activation. These data establish that AFC inhibition of EGF-stimulated Erk activation occurs at or above the level of Ras.
To confirm that AFC inhibited Ras methylation, COS-1 cells were dual-labeled with (Fig. 2D) . In contrast to inhibition of Erk, inhibition of methylation of nascent Ras by AFC was observable as early as 30 min after AFC exposure. The delay between the inhibition of methylation (30 min) and inhibition of Erk activation (12-24 h) suggested that AFC affects maturation and/or trafficking of Ras rather than its function as a GTPase.
The ability of AFC to inhibit Ras methylation did not formally exclude the possibility that AFC might also inhibit an upstream element of Ras in the Erk signaling pathway. Engagement of EGFR by EGF is the first step in the Erk signaling pathway and results in EGFR tyrosine phosphorylation and activation. As shown in Fig. 2E , stimulation of cells with EGF resulted in marked increases in tyrosine phosphorylation of EGFR. Preincubation with AFC for 18 h prior to EGF stimulation had no effect on the phosphorylation state of EGFR. Thus, AFC does not appear to affect signaling upstream of Ras.
Overexpression of pcCMT Enhances EGF-stimulated Erk Activation-The ability of AFC to inhibit Erk activation suggested that Ras methylation is requisite for Erk activation to proceed. We therefore tested whether increases in pcCMT activity result in increases in Erk activation. We have previously determined that transfection of the pcCMT into COS-1 cells results in increased membrane-associated methyltransferase activity directed toward Ras-related proteins (12) . As shown in Fig. 3 , transfection of cells with pcCMT resulted in no statistically significant increases in resting Erk activity compared with vector-transfected controls. However, pcCMT-transfected cells stimulated with EGF demonstrated increased Erk activity as compared with EGF-stimulated vector controls. Thus, pc-CMT activity appears to be necessary but not sufficient for Ras-mediated Erk activation.
Inhibition of Methylation Blocks Progression of Nascent Ras to PM and Depletes Ras from the PM-
The requirement for long AFC exposures to inhibit Erk activation, in contrast to the short exposures needed to inhibit methylation of nascent Ras, suggested that Ras methylation is unlikely to participate in rapid signaling but might rather represent a necessary prior alteration of Ras in order for signaling to proceed. We have previously reported that pre-exposure of COS-1 cells to AFC for 24 h resulted in diminished accumulation of GFP-NRas and GFP-KRas4B constructs at the PM and increased accumulation of the same constructs in the CS (9) . To confirm the ability of AFC to block the movement of Ras proteins to the PM, we transiently transfected COS-1 cells with GFP-Ras (GFP H-Ras, N-Ras, and K-Ras) followed by the addition of 150 M AFC or AGC, incubation for 18 h, and fluorescence microscopic examination. As shown in Fig. 4A , transfection of COS-1 cells with each GFP-Ras isoform in the presence of AGC resulted in the appearance of GFP-Ras at the PM. In contrast, incubation of cells expressing each isoform in the presence of AFC resulted in increased accumulation of Ras in the CS and diminished accumulation at the PM. Thus, AFC has the capacity to block the movement of nascent Ras to the PM. To confirm that blockade of Ras localization results in depletion of Ras already at the membrane, we tested the effects of AFC or AGC on MDCK cells stably transfected with GFP-tagged H-Ras, N-Ras, or K-Ras. As shown in Fig. 4B , MDCK cells stably transfected with each isoform of GFP-Ras and incubated with AGC for 18 h demonstrated fluorescence at the PM. In untreated cells PM fluorescence was also seen and remained stable throughout the observation period, confirming a steady-state distribution of PM GFP-Ras (not shown). In contrast, exposure to AFC for prolonged (18 h) but not brief (2 h) periods resulted in a marked depletion of GFP-Ras at the PM. These data confirm that inhibition of Ras methylation by AFC results in impaired movement of Ras to the PM and demonstrate for the first time that such impairment leads to the depletion of Ras at the PM. Moreover, although AFC inhibition of Ras methylation occurs rapidly after exposure, the time required to deplete PM Ras is much longer and is concordant with the kinetics of AFC inhibition of Erk activation. Because membrane localization of Ras is required for signal transduction leading to Erk activation (28) , these data suggest that carboxyl methylation regulates Erk at least in part by regulating membrane localization of Ras.
Effects of AFC on Cells Transfected with CD8-Ras Constructs-To test whether PM localization of Ras is the only means through which Ras methylation regulates Erk activation, we constructed a set of chimeras that included various combinations of GFP, H-Ras, and the CD8 receptor, a transmembrane protein that targets to the PM. MDCK cells stably transfected with GFP-H-Ras demonstrated GFP-H-Ras expression at the PM that was depleted after 18 h of exposure to AFC, accompanied by an accumulation of GFP-H-Ras in the CS. In contrast, MDCK cells stably transfected with CD8-GFP also showed expression of the labeled protein at the PM, but this localization was insensitive to AFC exposure (Fig. 5A) . When MDCK cells were transiently transfected with either GFP-HRas or CD8-H-Ras-GFP, exposure to AFC inhibited the PM accumulation of GFP-H-Ras but not CD8-H-Ras-GFP (Fig. 5B) . Thus, as expected, CD8-directed protein localization to the PM was methylation-independent and AFC-insensitive.
To test the effects of PM localization of Ras on Erk signaling, COS-1 cells were transiently transfected with H-Ras or CD8-H-Ras and incubated for 18 h in the absence or presence of 150 M AFC, followed by stimulation with EGF (30 min) and assay of Erk activation (Fig. 6) . COS-1 cells transfected with wildtype H-Ras demonstrated EGF-stimulated Erk activity, as expected. Moreover, stimulation of Erk activity in H-Ras transfectants was inhibited by preincubation with AFC. In contrast to H-Ras transfection, transfection with CD8-H-Ras resulted in increased Erk activation in the absence of stimulation and only a small additional response to EGF. Because CD8-H-Ras localized to the membrane in an AFC-resistant fashion, we hypoth- esized that Erk activation in these cells would be unaffected by AFC. Surprisingly, preincubation of CD8-H-Ras-transfected cells with AFC resulted in marked attenuation of EGF-stimulated Erk activation. Taken together, these data suggest that methylation of Ras not only regulates the Erk pathway through effects on Ras localization but also by an additional, direct effect on Ras signaling capability.
DISCUSSION
Methylation is the last step in the post-translational modification of the carboxyl terminal cysteine of Ras and other CAAX proteins. The conservation of methylation, despite high energy requirements for generating methyl donor intermediates, suggests the importance of carboxyl methylation to the regulation of cellular functions, but its precise roles are not yet well elucidated. The reversibility of carboxyl methylation suggests a possible role in the direct regulation of Ras-related signaling functions (17) . Indeed, some studies have demonstrated a correlation between agonist stimulation and transient increases in the methylation of some Ras-related proteins (8, 17) . Alternatively, carboxyl methylation of Ras and related proteins might serve as a strictly structural modification. Such a hypothesis is supported by the observation that the carboxyl methylation of farnesylated proteins increases their hydrophobicity and affinity to liposomes and membranes (5) . Our data suggest that for the Ras/Raf/MEK/Erk pathway, carboxyl methylation regulates both Ras localization and Ras signaling.
We observed that the pcCMT inhibitor AFC inhibited EGF stimulation of Erk as measured by both Erk phosphorylation and kinase activity. AFC had no direct effect on Erk, as evidenced by the failure of AFC to inhibit activity when added directly to purified activated Erk. AFC also inhibited Raf-1 and Mek activation, and kinetics and dose requirements for Mek inhibition closely correlated with those for Erk. On the other hand, AFC had no effect on EGF-stimulated phosphorylation of EGFR. We therefore conclude that AFC inhibition of the Ras/ Raf/Mek/Erk pathway occurs at the level of Ras. We attribute the effect of AFC specifically to the inhibition of Ras carboxyl methylation, because we confirmed the capacity of AFC but not AGC to inhibit Ras methylation in this system. Moreover, overexpression of pcCMT potentiated EGF-stimulated Erk activation, confirming a role for prenylcysteine-directed protein carboxyl methylation in the regulation of the Erk pathway. Ras is the only molecule in that pathway that is structurally susceptible to carboxyl methylation.
The long AFC exposure times required to inhibit EGF-stimulated Erk activation, together with the short exposure time sufficient to inhibit methylation of nascent Ras (12-24 versus Յ 1 h) suggested that Ras methylation precedes Ras signaling rather than serving as an integral event in the signaling process per se. Studies indicate that the movements of H-, N-, and K-Ras from the CS to the PM require association with the cytoplasmic face of the endomembrane en route and that, consistent with an ER localization of the CAAX-modifying proteases and pcCMT, Ras proteins are subject to modifications including methylation at endomembrane sites (9, 12) . Thus one possible mechanism for AFC inhibition of Erk activation would be to block the appropriate localization of Ras as required for Raf/Mek/Erk signaling. Consistent with this idea, inhibition of methylation by AFC blocked the movement of nascent GFPRas onto the PM. Moreover, long (12-24 h) but not short (2 h) exposures to AFC depleted GFP-Ras populations stably expressed at the PM. These data are consistent with a model in which blockade of Ras movement to the PM, together with turnover of Ras already at the PM, slowly depletes membrane Ras and eventually interrupts Ras signaling. Consistent with this model, the time to PM accumulation of nascent GFP-Ras is on the order of 12-18 h, and inhibition of protein synthesis by cycloheximide for 5 h is insufficient to cause depletion of PM GFP-Ras (9) .
Similar depletions of Ras from the PM have been seen in pcCMT null cells (23) and in cells treated with farnesyl thiosalicylate (FTS), another inhibitor of pcCMT (29) . Indeed, FTS inhibits Erk activation in EJ and Rat-1 cells stimulated with serum (30) . Inhibition of Erk by FTS was seen as early as two hours after exposure, suggesting that FTS has a mode of action distinct from AFC. Kloog and co-workers (29) have suggested that FTS directly dislodges Ras from the PM, resulting in Ras degradation. Consistent with this idea, FTS reduced PM Ras concentrations within 2 h, concordant with the kinetics of its effects on Erk. If correct, the ability of FTS to dislodge Ras rapidly, in a manner that does not depend upon normal protein trafficking pathways, might explain the difference in kinetics between AFC and FTS. In any event, the ability of both of these agents to inhibit Erk activation affirms the importance of proper Ras localization for Erk signaling. Of note, Kloog's group observed that AFC had no effect on Erk activation; however, both the concentration tested (50 M) and the time of exposure (2 h) were also inadequate for Erk inhibition in our own experiments. Indeed, we have previously shown the optimal dose of AFC required to inhibit carboxyl methylation to be on the order of 100 -150 M (21), depending partly on cell type.
To confirm that the ability of AFC to inhibit Erk activation was exclusively because of effects on Ras localization, we developed chimeric molecules consisting of H-Ras complexed to the cytoplasmic end of the CD8 receptor. We employed GFPlinked versions of these constructs to confirm that CD8-linked constructs localized to the PM and that CD8-dependent localization was AFC-insensitive. These observations permitted us to study Erk activation in cells in which Ras is expressed at the PM in an AFC-insensitive fashion. Overexpression of CD8-HRas increased the baseline activity of Erk to levels approaching those in EGF-stimulated cells overexpressing wild-type H-Ras. Thus association of Ras with membranes in a CAAX-independent fashion supported activity, consistent with prior studies (31) . EGF stimulation of CD8-H-Ras cells led to only small additional increases in Erk activation. Because CD8-H-Ras localization to the membrane did not require methylation, we predicted that AFC would not affect Erk activation in these cells. Surprisingly, Erk activity in EGF-stimulated cells expressing CD8-H-Ras was markedly inhibited by overnight exposure to AFC. EGF-stimulated Erk activity was also inhibited in cells transfected with CD8-H-Ras-SAAX, a Ras mutant that does not undergo CAAX processing (not shown). These data are consistent with our prior studies indicating that Ras tethered to membranes via an M1 anchor nonetheless requires CAAX processing for fibroblast transforming activity (28) . Thus, Ras methylation appears to be necessary both for Ras localization to the PM and for a subsequent Ras interaction critical to the transmission of signals. We speculate that the second role of Ras methylation may reside in a specific interaction with an unidentified accessory protein or may serve to localize Ras more tightly or precisely in the PM. Alternatively, methylation may regulate Ras interaction with its activator, Sos, or its effector, Raf-1. Indeed, studies have demonstrated that prenylation, a prerequisite for methylation, regulates the productive interaction of Ras with both Sos and Raf-1 (32) (33) (34) .
Although our data strongly suggest that carboxyl methylation is important for proper Ras trafficking and Raf/Mek/Erk signaling, AFC inhibition of EGF-induced Erk activation was incomplete, and maximal inhibition was in the range of 60 -70%. Although this partial effect might be because of incomplete inhibition of Ras methylation, it is also possible that Erk activation by EGF proceeds in part through a Ras-independent pathway(s). Consistent with this idea, a dominant negative Ras mutant (N17Ras) only partly blocked EGF stimulation of Erk in COS-1 cells (35) . Alternatively, carboxyl methylation might not be absolutely required for Ras signaling. Such an interpretation is consistent with a report that a dominant-active Ras mutant (H-Ras61L), targeted to the PM by a myristoylation sequence but lacking carboxyl terminal modification (i.e. neither prenylated nor methylated), retained diminished but persistent Raf-1-and Erk-activating capacity (31) . Another report indicates that a non-methylated, dominant-active K-Ras mutant (K-Ras12V, 187Y) retained ϳ55% of the transforming activity of the fully processed form as well as ϳ50% membrane association (36) . Because K-Ras differs from other isoforms by the presence of a polybasic domain that regulates localization (9, 14) , it is possible that this domain partially compensates for loss of methylation. Indeed, Booden et al. (37) have reported that a carboxyl terminal polybasic domain restored the transforming potential of a constitutively GTP-bound H-Ras whose CAAX box had been deleted. Regardless of these possible alternative mechanisms, our data demonstrate that prenylcysteinedirected carboxyl methylation plays a significant role in the regulation of Ras effector function.
